STOCK TITAN

KKR & (KKR) Stock News, Mar-Apr 2026

KKR NYSE

KKR & Co. Inc. reports developments across its global investment business, including alternative asset management, capital markets activity and insurance solutions. Company news commonly covers operating results, fund and strategy activity, portfolio investments, co-investment vehicles, debt financing, and capital-structure updates.

KKR sponsors investment funds in private equity, credit and real assets, works with strategic partners that manage hedge fund platforms, and operates insurance subsidiaries that offer retirement, life and reinsurance products through Global Atlantic Financial Group. Recent company updates also reflect activity in technology growth, sports, sustainable infrastructure and insurance-related platforms.

Rhea-AI Summary

KKR (KKR) appointed Lauren Goodwin as Managing Director and Chief Investment Strategist for Global Wealth Solutions, effective April 28, 2026. Goodwin will develop advisor-facing tools, applied research, and portfolio frameworks using KKR’s private markets expertise, Global Macro & Asset Allocation, and KKR Global Institute insights.

The announcement highlights KKR’s 50 years of private markets experience, a decade-plus Global Wealth Solutions track record, and K-Series distribution on over 180 platforms reaching thousands of advisors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
none
-
Rhea-AI Summary

Vertical Bridge (KKR) announced a $1.5 billion strategic equity investment from KKR to support future growth and establish a fully funded, long‑term capital structure. The company operates a nationwide portfolio of more than 17,000 towers; existing sponsors DigitalBridge and La Caisse also participated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.04%
Tags
none
-
Rhea-AI Summary

HealthCare Royalty (NYSE: KKR) announced a royalty monetization agreement with the Advisory Group representing former Oncoceutics securityholders for an undisclosed percentage of royalties on Modeyso (dordaviprone) commercial sales. Modeyso received U.S. FDA accelerated approval in August 2025 and is commercialized by Jazz Pharmaceuticals.

The agreement transfers a portion of future Modeyso royalties to HealthCare Royalty; financial terms and percentage were not disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
none
Rhea-AI Summary

KKR (NYSE:KKR) agreed to invest KRW 1.22 trillion ($820 million) in newly issued convertible bonds of Samsung SDS on April 14, 2026, forming a strategic partnership to support Samsung SDS’ expansion as a full‑stack AI solutions provider.

KKR will act as an active advisor on M&A, capital allocation and global growth; the transaction is expected to close in Q2 subject to customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.41%
Tags
partnership
-
Rhea-AI Summary

FS KKR Capital Corp (NYSE: FSK) will release first quarter 2026 results after market close on Wednesday, May 6, 2026. An investor presentation will be posted the same day. The company will host a live webcast conference call on Thursday, May 7, 2026 at 9:00 a.m. ET.

Research analysts should register at least one day prior or 15 minutes before the call; a replay will be available on the For Investors section of the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
conferences
-
Rhea-AI Summary

Apnimed secured a senior secured credit facility of up to $150 million from funds managed by HealthCare Royalty Partners to fund commercial readiness and a planned U.S. launch of AD109 for obstructive sleep apnea.

Apnimed will receive $50 million at closing, a second $50 million upon FDA approval of AD109, and a third $50 million upon a sales milestone. The deal includes a four-year interest-only period (five years if a net sales milestone is met) and a low single-digit synthetic royalty on AD109 net sales. Apnimed expects to submit an NDA for AD109 later this quarter, supported by positive Phase 3 SynAIRgy and LunAIRo results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
none
Rhea-AI Summary

KKR (NYSE: KKR) will release first quarter 2026 financial results on Tuesday, May 5, 2026, before market open. A conference call to discuss results is scheduled that day at 10:00 a.m. ET, with dial‑in access and a live webcast via KKR's Investor Center.

A replay of the webcast will be available on KKR's website about one hour after the live broadcast. KKR is described as a global investment firm offering alternative asset management, capital markets and insurance solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
earnings date
-
Rhea-AI Summary

KKR (KKR) closed KKR North America Fund XIV (NAX4) at approximately $23 billion on April 2, 2026, making it the largest private equity fund focused solely on North America. The firm cites a decade track record with a gross IRR of 23% (19% net) and a gross MOIC of 2.1x (1.8x net) as of December 31, 2025. KKR reports private equity AUM of approximately $229 billion and says NAX4 will continue support for broad-based employee ownership, noting 85 portfolio companies and >200,000 employees participating since 2011.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
-
Rhea-AI Summary

Global Atlantic 2026 Retirement Outlook finds the first wave of Gen X approaching retirement with markedly higher income anxiety than Boomers.

Key metrics: 28% of Gen X extremely/very concerned vs 14% of Boomers; 56% pension envy among Gen X without pensions; 48% expect to return to work; 61% prioritize protecting assets; 38% lack a retirement income plan; 69% worry Social Security won't provide full benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
none
Rhea-AI Summary

KKR (KKR) intends to acquire all common shares of Taiyo Holdings (TSE:4626) via a tender offer at JPY 4,750 per share, supported by Taiyo Holdings’ board and shareholders representing approximately 42.2% of shares as of March 31, 2026.

The price implies premiums of 117.19% and 140.14% versus two six-month unaffected averages; Oasis agreed to tender ~15.62%. Transaction is subject to customary conditions and regulatory approvals and includes post-close share consolidation, buyback and founding-family reinvestment in the KKR vehicle.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
none

FAQ

What is the current stock price of KKR & (KKR)?

The current stock price of KKR & (KKR) is $90.67 as of October 7, 2026.

What is the market cap of KKR & (KKR)?

The market cap of KKR & (KKR) is approximately 81.4B.